THE NEW DENTAL ANTIBIOTIC GUIDANCE
Antimicrobial Technology Symposium

Session 4

January 6, 2023
12 - 1:30 pm PT | 3 - 4:30 pm ET


 

TITLE: THE NEW DENTAL ANTIBIOTIC GUIDANCE

COURSE FEE:  Free

CREDITS: This continuing education activity is designated for 1.5 credits

AGD PACE SUBJECT CODE:  134 Prescription Medication Management

CE SUPPORTER: Perio Protect

MODE: Electronically Mediated | Live Lecture | Interactive Webinar

SPEAKER: Debra Goff PharmD, FIDSA, FCCP BIO HERE

AUDIENCE: Dentists, Dental Hygienists, Dental Therapists, Dental Assistants

TECHNOLOGY REQUIRED:  Mobile device, laptop or desktop with internet connection | Google Chrome Browser

COURSE SUMMARY:  This program aims to discuss new dental literature on the prophylactic and therapeutic use of antibiotics to guide dentists to make appropriate antibiotic decisions. Dentists prescribe approximately 10% of all outpatient antibiotic prescriptions in the United States (US), writing more than 25.7 million prescriptions per year. Dentists not only prescribe a significant proportion of antibiotics, but dentists are also the top prescribers of clindamycin in the United States, which is the most common antibiotic to cause Clostridium difficile infections. Over 80% of antibiotics prescribed by dentists for prophylaxis have been found to be unnecessary. Dental antibiotic prescriptions for therapeutic use are frequently written for durations of 7, 10, and 14 days with little data to support the prolong durations. Conflicting scientific evidence, lack of evidence, fear of lawsuits and lack of new information on antibiotic risks are factors that contribute to inappropriate antibiotic use. The overuse and misuse ofantibiotics in dentistry contributes to antibiotic resistance, costs and patient harm.

LEARNING OBJECTIVES: 

  1. ​Review new guidance on the use of clindamycin and quinolones

  2. Discuss 5 antibiotic practice changes dentists should make

  3. Describe the prevalence of antibiotic resistance and its impact on dental patients

  4. Analyze new studies that evaluate dental antibiotic use for prophylaxis and treatment

  5. Define the role of dentists in dental antibiotic stewardship based on the ADA endorsement of the Centers for Disease Control and Prevention (CDC) recommendations for dentists.

Debra Goff PharmD, FIDSA, FCCP

Speaker: Debra Goff PharmD, FIDSA, FCCP; Professor of Pharmacy Practice, Infectious Diseases Clinical Pharmacist.

The Ohio State University Wexner Medical Center 

Dr. Goff is an infectious diseases clinical pharmacist and the founding member of the  Antibiotic Stewardship Program (ASP) at The Ohio State University Wexner Medical Center (OSUWMC). Dr.Goff collaborated with the CDC on the first Dental Antibiotic Stewardship initiative involving private practice dentists and orthopedic surgeons in June 2018 Columbus OH. They examined one of the most challenging topics in dentistry; the use of dental antibiotic prophylaxis in joint implant patients. Thirty local dentists and orthopedic surgeons participated in their workshop. She conducted the first US study with private practice dentists to evaluate their antibiotic prescribing and identify appropriate use. She has experience working with dentists and listening to the educational needs of dentists related to the appropriate use of antibiotics.She founded the OSU-South Africa Train-the-Trainer Antibiotic Stewardship Program in 2012 and received the 2019 OSU Distinguished International Outreach and Engagement Award for herwork in South Africa. Dr. Goff is one of twenty-five global experts selected by the World HealthOrganization (WHO) to implement antibiotic stewardship programs in low-middle incomecountries. She lectures nationally and internationally and has over 110 peer-reviewedpublications and 50 grants.

 

DISCLOSURE OF SPEAKER AND FACULTY COMMERCIAL RELATIONSHIPS:  According to Dental CE Academy's  Conflict of Interest and Disclosure Policy, faculty and speakers for any course are expected to disclose any economic support, personal interests, or potential bias that may be perceived as creating a conflict related to the material being presented. Disclosure statements are printed in each course description and announced by moderators or individual speakers at the beginning of each presentation. This policy is intended to alert the audience to any potential bias or conflict so that participants may form their own judgments about the material being presented.

CONFLICT OF INTEREST AND FINANCIAL DISCLOSURE:  This course is supported by Perio Protect. The speaker, Dr. Goff has received a speaker's honorarium from Perio Protect. She discloses no other financial affiliation with Perio Protect.  

For written documentation contact support@dentalcenow.com.

 

DENTAL CE ACADEMY DISCLOSURE: The views expressed and opinions and materials presented during these live and recorded presentations represent the personal views and opinions of the individual speaker and do not necessarily represent the views and opinions of Dental CE Academy.  Dental CE Academy assumes no responsibility for the content of the presentations made by the individual speakers. Any suggested protocols for treatment, materials, or services may be based up on the speakers' own clinican experience and should not be construed as Dental CE Academy recommended or endorsed. Selected presentations may include exploratory research or experimental procedures and are intended for informational purposes that may lead to new interest and scientific breakthroughs in the fields of dentistry.  Dental CE Academy appreciates its educators who share their knowledge and expertise. This level of dedication to dentistry allows our profession to expand and thrive and provokes necessary discussion and understanding.